Additional research will help clarify whether the BCEV-driven elicitation of robust CCL2 production plays any role in BC recurrence or primary BC tumor progression, with smoking or E-cigarette use potentially exacerbating any emergent oncogenic phenotypes. Here, CCL2 is linked to breast cancer.